Advertisement
Original Article| Volume 62, ISSUE 4, P345-354, August 15, 2007

Download started.

Ok

Seizure Incidence in Psychopharmacological Clinical Trials: An Analysis of Food and Drug Administration (FDA) Summary Basis of Approval Reports

      Background

      Clinical trial data provide an approach to the investigation of the effects of psychopharmacological agents, and psychiatric disorders themselves, on seizure threshold.

      Methods

      We accessed public domain data from Food and Drug Administration (FDA) Phase II and III clinical trials as Summary Basis of Approval (SBA) reports that noted seizure incidence in trials of psychotropic drugs approved in the United States between 1985 and 2004, involving a total of 75,873 patients. We compared seizure incidence among active drug and placebo groups in psychopharmacological clinical trials and the published rates of unprovoked seizures in the general population.

      Results

      Increased seizure incidence was observed with antipsychotics that was accounted for by clozapine and olanzapine, and with drugs indicated for the treatment of OCD that was accounted for by clomipramine. Alprazolam, bupropion immediate release (IR) form, and quetiapine were also associated with higher seizure incidence. The incidence of seizures was significantly lower among patients assigned to antidepressants compared to placebo (standardized incidence ratio = .48; 95% CI, .36- .61). In patients assigned to placebo, seizure incidence was greater than the published incidence of unprovoked seizures in community nonpatient samples.

      Conclusions

      Proconvulsant effects are associated with a subgroup of psychotropic drugs. Second-generation antidepressants other than bupropion have an apparent anticonvulsant effect. Depression, psychotic disorders, and OCD are associated with reduced seizure threshold.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Alper K.
        • Devinsky O.
        • Westbrook L.
        • Luciano D.
        • Pacia S.
        • Perrine K.
        • Vazquez B.
        Premorbid psychiatric risk factors for postictal psychosis.
        J Neuropsychiatry Clin Neurosci. 2001; 13: 492-499
        • Amann B.L.
        • Pogarell O.
        • Mergl R.
        • Juckel G.
        • Grunze H.
        • Mulert C.
        • Hegerl U.
        EEG abnormalities associated with antipsychotics: A comparison of quetiapine, olanzapine, haloperidol and healthy subjects.
        Hum Psychopharmacol. 2003; 18: 641-646
        • Annegers J.F.
        • Hauser W.A.
        • Coan S.P.
        • Rocca W.A.
        A population-based study of seizures after traumatic brain injuries.
        N Engl J Med. 1998; 338: 20-24
        • Armitage P.
        • Berry G.
        Statistical Methods in Medical Research. 1994 (Blackwell)
        • Balit C.R.
        • Isbister G.K.
        • Hackett L.P.
        • Whyte I.M.
        Quetiapine poisoning: A case series.
        Ann Emerg Med. 2003; 42: 751-758
        • Balit C.R.
        • Lynch C.N.
        • Isbister G.K.
        Bupropion poisoning: A case series.
        Med J Aust. 2003; 178: 61-63
        • Banasr M.
        • Soumier A.
        • Hery M.
        • Mocaer E.
        • Daszuta A.
        Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis.
        Biol Psychiatry. 2006; 59: 1087-1096
        • Bausch S.B.
        Axonal sprouting of GABAergic interneurons in temporal lobe epilepsy.
        Epilepsy Behav. 2005; 7: 390-400
        • Borowicz K.K.
        • Stepien K.
        • Czuczwar S.J.
        Fluoxetine enhances the anticonvulsant effects of conventional antiepileptic drugs in maximal electroshock seizures in mice.
        Pharmacol Rep. 2006; 58: 83-90
        • Boylan L.S.
        • Flint L.A.
        • Labovitz D.L.
        • Jackson S.C.
        • Starner K.
        • Devinsky O.
        Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy.
        Neurology. 2004; 62: 258-261
        • Brambilla P.
        • Perez J.
        • Barale F.
        • Schettini G.
        • Soares J.C.
        GABAergic dysfunction in mood disorders.
        Mol Psychiatry. 2003; 8 (715): 721-737
        • Brodkin E.S.
        • McDougle C.J.
        • Naylor S.T.
        • Cohen D.J.
        • Price L.H.
        Clomipramine in adults with pervasive developmental disorders: A prospective open-label investigation.
        J Child Adolesc Psychopharmacol. 1997; 7: 109-121
        • Browne J.L.
        • Hauge K.J.
        A review of alprazolam withdrawal.
        Drug Intell Clin Pharm. 1986; 20: 837-841
        • Buckley N.A.
        • Dawson A.H.
        • Whyte I.M.
        • Henry D.A.
        Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants.
        Lancet. 1994; 343: 159-162
        • Camacho A.
        • Garcia-Navarro M.
        • Martinez B.
        • Villarejo A.
        • Pomares E.
        Olanzapine-induced myoclonic status.
        Clin Neuropharmacol. 2005; 28: 145-147
        • Centorrino F.
        • Price B.H.
        • Tuttle M.
        • Bahk W.M.
        • Hennen J.
        • Albert M.J.
        • Baldessarini R.J.
        EEG abnormalities during treatment with typical and atypical antipsychotics.
        Am J Psychiatry. 2002; 159: 109-115
        • Clinckers R.
        • Gheuens S.
        • Smolders I.
        • Meurs A.
        • Ebinger G.
        • Michotte Y.
        In vivo modulatory action of extracellular glutamate on the anticonvulsant effects of hippocampal dopamine and serotonin.
        Epilepsia. 2005; 46: 828-836
        • Clinckers R.
        • Smolders I.
        • Meurs A.
        • Ebinger G.
        • Michotte Y.
        Anticonvulsant action of GBR-12909 and citalopram against acute experimentally induced limbic seizures.
        Neuropharmacology. 2004; 47: 1053-1061
        • Clinckers R.
        • Smolders I.
        • Meurs A.
        • Ebinger G.
        • Michotte Y.
        Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors.
        J Neurochem. 2004; 89: 834-843
        • Cossart R.
        • Bernard C.
        • Ben-Ari Y.
        Multiple facets of GABAergic neurons and synapses: Multiple fates of GABA signalling in epilepsies.
        Trends Neurosci. 2005; 28: 108-115
        • Coughlin P.A.
        • Birkinshaw R.I.
        Zyban: Increasing the workload in an accident and emergency department?.
        Eur J Emerg Med. 2003; 10: 62-63
        • Cramer J.A.
        • Blum D.
        • Reed M.
        • Fanning K.
        The influence of comorbid depression on quality of life for people with epilepsy.
        Epilepsy Behav. 2003; 4: 515-521
        • Cuenca P.J.
        • Holt K.R.
        • Hoefle J.D.
        Seizure secondary to citalopram overdose.
        J Emerg Med. 2004; 26: 177-181
        • Dailey J.W.
        • Naritoku D.K.
        Antidepressants and seizures: Clinical anecdotes overshadow neuroscience.
        Biochem Pharmacol. 1996; 52: 1323-1329
        • Dailey J.W.
        • Yan Q.S.
        • Mishra P.K.
        • Burger R.L.
        • Jobe P.C.
        Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats.
        J Pharmacol Exp Ther. 1992; 260: 533-540
        • Davidson J.
        Seizures and bupropion: A review.
        J Clin Psychiatry. 1989; 50: 256-261
        • de Lanerolle N.C.
        • Lee T.S.
        New facets of the neuropathology and molecular profile of human temporal lobe epilepsy.
        Epilepsy Behav. 2005; 7: 190-203
        • Devinsky O.
        • Honigfeld G.
        • Patin J.
        Clozapine-related seizures.
        Neurology. 1991; 41: 369-371
        • Dogu O.
        • Sevim S.
        • Kaleagasi H.S.
        Seizures associated with quetiapine treatment.
        Ann Pharmacother. 2003; 37: 1224-1227
        • Dunner D.L.
        • Zisook S.
        • Billow A.A.
        • Batey S.R.
        • Johnston J.A.
        • Ascher J.A.
        A prospective safety surveillance study for bupropion sustained-release in the treatment of depression.
        J Clin Psychiatry. 1998; 59: 366-373
        • Favale E.
        • Audenino D.
        • Cocito L.
        • Albano C.
        The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis.
        Seizure. 2003; 12: 316-318
        • Favale E.
        • Rubino V.
        • Mainardi P.
        • Lunardi G.
        • Albano C.
        Anticonvulsant effect of fluoxetine in humans.
        Neurology. 1995; 45: 1926-1927
        • Forsgren L.
        • Nystrom L.
        An incident case-referent study of epileptic seizures in adults.
        Epilepsy Res. 1990; 6: 66-81
        • Fromm G.H.
        • Wessel H.B.
        • Glass J.D.
        • Alvin J.D.
        • Van Horn G.
        Imipramine in absence and myoclonic-astatic seizures.
        Neurology. 1978; 28: 953-957
        • Gaitatzis A.
        • Trimble M.R.
        • Sander J.W.
        The psychiatric comorbidity of epilepsy.
        Acta Neurol Scand. 2004; 110: 207-220
        • Gilliam F.
        • Hecimovic H.
        • Sheline Y.
        Psychiatric comorbidity, health, and function in epilepsy.
        Epilepsy Behav. 2003; 4: S26-S30
        • GlaxoSmithKline
        Wellbutrin SR® (bupropion hydrochloride) sustained-release tablets prescribing information. 2006
        • GlaxoSmithKline
        Wellbutrin® (bupropion hydrochloride) tablets prescribing information. 2006
        • Gross A.
        • Devinsky O.
        • Westbrook L.E.
        • Wharton A.H.
        • Alper K.
        Psychotropic medication use in patients with epilepsy: Effect on seizure frequency.
        J Neuropsychiatry Clin Neurosci. 2000; 12: 458-464
        • Gunther W.
        • Baghai T.
        • Naber D.
        • Spatz R.
        • Hippius H.
        EEG alterations and seizures during treatment with clozapine.
        Pharmacopsychiatry. 1993; 26: 69-74
        • Harmant J.
        • van Rijckevorsel-Harmant K.
        • de Barsy T.
        • Hendrickx B.
        Fluvoxamine: An antidepressant with low (or no) epileptogenic effect.
        Lancet. 1990; 336: 386
        • Hauser W.A.
        • Annegers J.F.
        • Kurland L.T.
        Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984.
        Epilepsia. 1993; 34: 453-468
        • Hedges D.
        • Jeppson K.
        • Whitehead P.
        Antipsychotic medication and seizures: A review.
        Drugs Today (Barc). 2003; 39: 551-557
        • Hedges D.W.
        • Jeppson K.G.
        New-onset seizure associated with quetiapine and olanzapine.
        Ann Pharmacother. 2002; 36: 437-439
        • Hesdorffer D.C.
        • Hauser W.A.
        • Annegers J.F.
        • Cascino G.
        Major depression is a risk factor for seizures in older adults.
        Ann Neurol. 2000; 47: 246-249
        • Hesdorffer D.C.
        • Hauser W.A.
        • Olafsson E.
        • Ludvigsson P.
        • Kjartansson O.
        Depression and suicide attempt as risk factors for incident unprovoked seizures.
        Ann Neurol. 2006; 59: 35-41
        • Horne R.L.
        • Ferguson J.M.
        • Pope Jr, H.G.
        • Hudson J.I.
        • Lineberry C.G.
        • Ascher J.
        • Cato A.
        Treatment of bulimia with bupropion: A multicenter controlled trial.
        J Clin Psychiatry. 1988; 49: 262-266
        • Hovorka J.
        • Herman E.
        • Nemcova I.I.
        Treatment of interictal depression with citalopram in patients with epilepsy.
        Epilepsy Behav. 2000; 1: 444-447
        • Hurst D.L.
        The use of imipramine in minor motor seizures.
        Pediatr Neurol. 1986; 2: 13-17
        • Hyde T.M.
        • Weinberger D.R.
        Seizures and schizophrenia.
        Schizophr Bull. 1997; 23: 611-622
        • Isbister G.K.
        • Bowe S.J.
        • Dawson A.
        • Whyte I.M.
        Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose.
        J Toxicol Clin Toxicol. 2004; 42: 277-285
        • Janicak P.G.
        • Davis J.M.
        • Preskorn S.H.
        • Ayd F.J.
        Principles and practice of psychopharmotherapy. third edition. Lippincott Williams and Wilkins, Philadelphia2001
        • Jefferson J.W.
        • Pradko J.F.
        • Muir K.T.
        Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations.
        Clin Ther. 2005; 27: 1685-1695
        • Jick S.S.
        • Jick H.
        • Knauss T.A.
        • Dean A.D.
        Antidepressants and convulsions.
        J Clin Psychopharmacol. 1992; 12: 241-245
        • Jobe P.C.
        Common pathogenic mechanisms between depression and epilepsy: An experimental perspective.
        Epilepsy Behav. 2003; 4: S14-S24
        • Jobe P.C.
        • Browning R.A.
        The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant.
        Epilepsy Behav. 2005; 7: 602-619
        • Johnston J.A.
        • Lineberry C.G.
        • Ascher J.A.
        • Davidson J.
        • Khayrallah M.A.
        • Feighner J.P.
        • Stark P.
        A 102-center prospective study of seizure in association with bupropion.
        J Clin Psychiatry. 1991; 52: 450-456
        • Jones J.E.
        • Hermann B.P.
        • Barry J.J.
        • Gilliam F.G.
        • Kanner A.M.
        • Meador K.J.
        Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy.
        Epilepsy Behav. 2003; 4: S31-S38
        • Kabuto H.
        • Yokoi I.
        • Takei M.
        • Kurimoto T.
        • Mori A.
        The anticonvulsant effect of citalopram on El mice, and the levels of tryptophan and tyrosine and their metabolites in the brain.
        Neurochem Res. 1994; 19: 463-467
        • Kanner A.M.
        Depression in epilepsy: Prevalence, clinical semiology, pathogenic mechanisms, and treatment.
        Biol Psychiatry. 2003; 54: 388-398
        • Kanner A.M.
        Epilepsy, suicidal behaviour, and depression: Do they share common pathogenic mechanisms?.
        Lancet Neurol. 2006; 5: 107-108
        • Kanner A.M.
        • Kozak A.M.
        • Frey M.
        The use of sertraline in patients with epilepsy: Is it safe?.
        Epilepsy Behav. 2000; 1: 100-105
        • Kecskemeti V.
        • Rusznak Z.
        • Riba P.
        • Pal B.
        • Wagner R.
        • Harasztosi C.
        • et al.
        Norfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies.
        Brain Res Bull. 2005; 67: 126-132
        • Keele N.B.
        The role of serotonin in impulsive and aggressive behaviors associated with epilepsy-like neuronal hyperexcitability in the amygdala.
        Epilepsy Behav. 2005; 7: 325-335
        • Kelly C.A.
        • Dhaun N.
        • Laing W.J.
        • Strachan F.E.
        • Good A.M.
        • Bateman D.N.
        Comparative toxicity of citalopram and the newer antidepressants after overdose.
        J Toxicol Clin Toxicol. 2004; 42: 67-71
        • Khan A.
        • Khan S.
        • Kolts R.
        • Brown W.A.
        Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: Analysis of FDA reports.
        Am J Psychiatry. 2003; 160: 790-792
        • Khan A.
        • Khan S.R.
        • Leventhal R.M.
        • Brown W.A.
        Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: An analysis of the food and drug administration database.
        Am J Psychiatry. 2001; 158: 1449-1454
        • Khan A.
        • Leventhal R.M.
        • Khan S.
        • Brown W.A.
        Suicide risk in patients with anxiety disorders: A meta-analysis of the FDA database.
        J Affect Disord. 2002; 68: 183-190
        • Khan A.
        • Warner H.A.
        • Brown W.A.
        Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: An analysis of the Food and Drug Administration database.
        Arch Gen Psychiatry. 2000; 57: 311-317
        • Kotsopoulos I.A.
        • van Merode T.
        • Kessels F.G.
        • de Krom M.C.
        • Knottnerus J.A.
        Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures.
        Epilepsia. 2002; 43: 1402-1409
        • Krijzer F.
        • Snelder M.
        • Bradford D.
        Comparison of the (pro)convulsive properties of fluvoxamine and clovoxamine with eight other antidepressants in an animal model.
        Neuropsychobiology. 1984; 12: 249-254
        • Kuhn K.U.
        • Quednow B.B.
        • Thiel M.
        • Falkai P.
        • Maier W.
        • Elger C.E.
        Antidepressive treatment in patients with temporal lobe epilepsy and major depression: A prospective study with three different antidepressants.
        Epilepsy Behav. 2003; 4: 674-679
        • Leander J.D.
        Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine, and ameltolide (LY201116).
        Epilepsia. 1992; 33: 573-576
        • Lee J.W.
        • Crismon M.L.
        • Dorson P.G.
        Seizure associated with olanzapine.
        Ann Pharmacother. 1999; 33: 554-556
        • Lee K.C.
        • Finley P.R.
        • Alldredge B.K.
        Risk of seizures associated with psychotropic medications: Emphasis on new drugs and new findings.
        Expert Opin Drug Saf. 2003; 2: 233-247
        • Logsdail S.J.
        • Toone B.K.
        Post-ictal psychoses.
        Br J Psychiatry. 1988; 152: 246-252
        • Luchins D.J.
        • Oliver A.P.
        • Wyatt R.J.
        Seizures with antidepressants: An in vitro technique to assess relative risk.
        Epilepsia. 1984; 25: 25-32
        • Malaspina D.
        • Goetz R.R.
        • Friedman J.H.
        • Kaufmann C.A.
        • Faraone S.V.
        • Tsuang M.
        • et al.
        Traumatic brain injury and schizophrenia in members of schizophrenia and bipolar disorder pedigrees.
        Am J Psychiatry. 2001; 158: 440-446
        • Malberg J.E.
        • Blendy J.A.
        Antidepressant action: To the nucleus and beyond.
        Trends Pharmacol Sci. 2005; 26: 631-638
        • Martin A.
        • Koenig K.
        • Scahill L.
        • Bregman J.
        Open-label quetiapine in the treatment of children and adolescents with autistic disorder.
        J Child Adolesc Psychopharmacol. 1999; 9: 99-107
        • Mehta C.R.
        • Patel N.R.
        A network algorithm for performing Fisher’s exact test in r x c contingency tables.
        J Am Stat Assoc. 1983; 78: 427-434
        • Mendez M.F.
        • Cummings J.L.
        • Benson D.F.
        Psychotropic drugs and epilepsy.
        Stress Medicine. 1986; 2: 325-332
        • Monaco F.
        • Cavanna A.
        • Magli E.
        • Barbagli D.
        • Collimedaglia L.
        • Cantello R.
        • Mula M.
        Obsessionality, obsessive-compulsive disorder, and temporal lobe epilepsy.
        Epilepsy Behav. 2005; 7: 491-496
        • Munchau A.
        • Langosch J.M.
        • Gerschlager W.
        • Rothwell J.C.
        • Orth M.
        • Trimble M.R.
        Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression.
        J Neurol Neurosurg Psychiatry. 2005; 76: 527-533
        • Nelson J.
        • Chouinard G.
        • Canadian Society for Clinical Pharmacology
        Guidelines for the clinical use of benzodiazepines: Pharmacokinetics, dependency, rebound and withdrawal.
        Can J Clin Pharmacol. 1999; 6: 69-83
        • Novartis
        Anafranil® clomipramine hydrochloride capsules prescribing information rev. 020605. 2006
        • Noyes Jr, R.
        • Perry P.J.
        • Crowe R.R.
        • Coryell W.H.
        • Clancy J.
        • Yamada T.
        • Gabel J.
        Seizures following the withdrawal of alprazolam.
        J Nerv Ment Dis. 1986; 174: 50-52
        • Ojemann L.M.
        • Baugh-Bookman C.
        • Dudley D.L.
        Effect of psychotropic medications on seizure control in patients with epilepsy.
        Neurology. 1987; 37: 1525-1527
        • Ojemann L.M.
        • Friel P.N.
        • Trejo W.J.
        • Dudley D.L.
        Effect of doxepin on seizure frequency in depressed epileptic patients.
        Neurology. 1983; 33: 646-648
        • Olafsson E.
        • Ludvigsson P.
        • Gudmundsson G.
        • Hesdorffer D.
        • Kjartansson O.
        • Hauser W.A.
        Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: A prospective study.
        Lancet Neurol. 2005; 4: 627-634
        • Pacia S.V.
        • Devinsky O.
        Clozapine-related seizures: Experience with 5,629 patients.
        Neurology. 1994; 44: 2247-2249
        • Pasini A.
        • Tortorella A.
        • Gale K.
        Anticonvulsant effect of intranigral fluoxetine.
        Brain Res. 1992; 593: 287-290
        • Pasini A.
        • Tortorella A.
        • Gale K.
        The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin.
        Brain Res. 1996; 724: 84-88
        • Pericic D.
        • Lazic J.
        • Svob Strac D.
        Anticonvulsant effects of acute and repeated fluoxetine treatment in unstressed and stressed mice.
        Brain Res. 2005; 1033: 90-95
        • Perneger T.V.
        What’s wrong with Bonferroni adjustments.
        BMJ. 1998; 316: 1236-1238
        • Pesola G.R.
        • Avasarala J.
        Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department.
        J Emerg Med. 2002; 22: 235-239
        • Peuskens J.
        • Link C.G.
        A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia.
        Acta Psychiatr Scand. 1997; 96: 265-273
        • Pillmann F.
        • Schlote K.
        • Broich K.
        • Marneros A.
        Electroencephalogram alterations during treatment with olanzapine.
        Psychopharmacology (Berl). 2000; 150: 216-219
        • Pisani F.
        • Oteri G.
        • Costa C.
        • Di Raimondo G.
        • Di Perri R.
        Effects of psychotropic drugs on seizure threshold.
        Drug Saf. 2002; 25: 91-110
        • Pisani F.
        • Spina E.
        • Oteri G.
        Antidepressant drugs and seizure susceptibility: From in vitro data to clinical practice.
        Epilepsia. 1999; 40: S48-S56
        • Pope Jr., H.G.
        • McElroy S.L.
        • Keck P.E.
        • Hudson J.I.
        • Ferguson J.M.
        • Horne R.L.
        Electrophysiological abnormalities in bulimia and their implications for pharmacotherapy: A reassessment.
        Internat J Eating Dis. 1989; 8: 191-201
        • Post R.M.
        Neurobiology of seizures and behavioral abnormalities.
        Epilepsia. 2004; 45: 5-14
        • Pozzi L.
        • Invernizzi R.
        • Garavaglia C.
        • Samanin R.
        Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: A comparison with citalopram.
        J Neurochem. 1999; 73: 1051-1057
        • Prendiville S.
        • Gale K.
        Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats.
        Epilepsia. 1993; 34: 381-384
        • Preskorn S.H.
        • Fast G.A.
        Tricyclic antidepressant-induced seizures and plasma drug concentration.
        J Clin Psychiatry. 1992; 53: 160-162
        • Qin P.
        • Xu H.
        • Laursen T.M.
        • Vestergaard M.
        • Mortensen P.B.
        Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: Population based cohort study.
        BMJ. 2005; 331: 23
        • Robinson M.L.
        Epileptic fit after clomipramine.
        Br J Psychiatry. 1978; 132: 525-526
        • Rosenstein D.L.
        • Nelson J.C.
        • Jacobs S.C.
        Seizures associated with antidepressants: A review.
        J Clin Psychiatry. 1993; 54: 289-299
        • Sachdev P.
        Schizophrenia-like psychosis and epilepsy: The status of the association.
        Am J Psychiatry. 1998; 155: 325-336
        • Sachdev P.
        The psychoses of epilepsy.
        J Neurol Neurosurg Psychiatry. 2001; 70: 708-709
        • Sajatovic M.
        • Meltzer H.Y.
        Clozapine-induced myoclonus and generalized seizures.
        Biol Psychiatry. 1996; 39: 367-370
        • Sajatovic M.
        • Ramirez L.
        Clozapine therapy in patients with neurologic illness.
        Int J Psychiatry Med. 1995; 25: 331-344
        • Sakakihara Y.
        • Oka A.
        • Kubota M.
        • Ohashi Y.
        Reduction of seizure frequency with clomipramine in patients with complex partial seizures.
        Brain Dev. 1995; 17: 291-293
        • Sanacora G.
        • Gueorguieva R.
        • Epperson C.N.
        • Wu Y.T.
        • Appel M.
        • Rothman D.L.
        • et al.
        Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression.
        Arch Gen Psychiatry. 2004; 61: 705-713
        • Shepherd G.
        • Velez L.I.
        • Keyes D.C.
        Intentional bupropion overdoses.
        J Emerg Med. 2004; 27: 147-151
        • Skowron D.M.
        • Stimmel G.L.
        Antidepressants and the risk of seizures.
        Pharmacotherapy. 1992; 12: 18-22
        • Sparks D.L.
        • Buckholtz N.S.
        Combined inhibition of serotonin uptake and oxidative deamination attenuates audiogenic seizures in DBA/2J mice.
        Pharmacol Biochem Behav. 1985; 23: 753-757
        • Specchio L.M.
        • Iudice A.
        • Specchio N.
        • La Neve A.
        • Spinelli A.
        • Galli R.
        • et al.
        Citalopram as treatment of depression in patients with epilepsy.
        Clin Neuropharmacol. 2004; 27: 133-136
        • Spigset O.
        • Hedenmalm K.
        • Dahl M.L.
        • Wiholm B.E.
        • Dahlqvist R.
        Seizures and myoclonus associated with antidepressant treatment: Assessment of potential risk factors, including CYP2D6 and CYP2C19 polymorphisms, and treatment with CYP2D6 inhibitors.
        Acta Psychiatr Scand. 1997; 96: 379-384
        • StatsDirect
        StatsDirect. 2.5.6 ed. 2006 (Cheshire, UK)
        • Stefansson S.B.
        • Olafsson E.
        • Hauser W.A.
        Psychiatric morbidity in epilepsy: A case controlled study of adults receiving disability benefits.
        J Neurol Neurosurg Psychiatry. 1998; 64: 238-241
        • Stimmel G.L.
        • Dopheide J.A.
        Psychotropic drug-induced reductions in seizure threshold: Incidence and consequences.
        CNS Drugs. 1996; 5: 37-50
        • Stockmeier C.A.
        • Mahajan G.J.
        • Konick L.C.
        • Overholser J.C.
        • Jurjus G.J.
        • Meltzer H.Y.
        • et al.
        Cellular changes in the postmortem hippocampus in major depression.
        Biol Psychiatry. 2004; 56: 640-650
        • Swinkels W.A.
        • Kuyk J.
        • van Dyck R.
        • Spinhoven P.
        Psychiatric comorbidity in epilepsy.
        Epilepsy Behav. 2005; 7: 37-50
        • Thapar A.
        • Roland M.
        • Harold G.
        Do depression symptoms predict seizure frequency--or vice versa?.
        J Psychosom Res. 2005; 59: 269-274
        • Theodore W.H.
        Epilepsy and depression: Imaging potential common factors.
        Clin EEG Neurosci. 2004; 35: 38-45
        • Trimble M.
        • Anlezark G.
        • Meldrum B.
        Seizure activity in photosensitive baboons following antidepressant drugs and the role of serotoninergic mechanisms.
        Psychopharmacology (Berl). 1977; 51: 159-164
        • Tutka P.
        • Barczynski B.
        • Wielosz M.
        Convulsant and anticonvulsant effects of bupropion in mice.
        Eur J Pharmacol. 2004; 499: 117-120
        • Ugale R.R.
        • Mittal N.
        • Hirani K.
        • Chopde C.T.
        Essentiality of central GABAergic neuroactive steroid allopregnanolone for anticonvulsant action of fluoxetine against pentylenetetrazole-induced seizures in mice.
        Brain Res. 2004; 1023: 102-111
        • US Department of Justice
        The Freedom of Information Act 5 U.S.C. § 552, As Amended By Public Law No. 104-231, 110 Stat 3048.
        FOIA Update. 1996; XVII
        • Wada Y.
        • Hirao N.
        • Shiraishi J.
        • Nakamura M.
        • Koshino Y.
        Pindolol potentiates the effect of fluoxetine on hippocampal seizures in rats.
        Neurosci Lett. 1999; 267: 61-64
        • Wada Y.
        • Shiraishi J.
        • Nakamura M.
        • Hasegawa H.
        Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats.
        Psychopharmacology (Berl). 1995; 118: 305-309
        • Wedin G.P.
        • Oderda G.M.
        • Klein-Schwartz W.
        • Gorman R.L.
        Relative toxicity of cyclic antidepressants.
        Ann Emerg Med. 1986; 15: 797-804
        • Whyte I.M.
        • Dawson A.H.
        • Buckley N.A.
        Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants.
        QJM. 2003; 96: 369-374
        • Woolley J.
        • Smith S.
        Lowered seizure threshold on olanzapine.
        Br J Psychiatry. 2001; 178: 85-86
        • Worthley D.L.
        • Burgess N.
        • Nigro O.
        • Shakib S.
        Seroquel, serzone and seizures.
        Intern Med J. 2004; 34: 134-135
        • Yoshitake T.
        • Reenila I.
        • Ogren S.O.
        • Hokfelt T.
        • Kehr J.
        Galanin attenuates basal and antidepressant drug-induced increase of extracellular serotonin and noradrenaline levels in the rat hippocampus.
        Neurosci Lett. 2003; 339: 239-242